|
Market Closed -
Australian S.E.
07:10:32 16/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1200 AUD | 0.00% |
|
-7.69% | -20.00% |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 61.6 | - | - |
| Change | - | - | 343.99% | -48.91% | - | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 43.7 | 38.2 | 44.2 |
| Change | - | - | 241.42% | -52.87% | -12.59% | 15.71% |
| P/E | -2.64x | -3.27x | -14.3x | -5.22x | -17.1x | -10.9x |
| PBR | - | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.1x | 0.2x | -0.2x |
| Capitalization / Revenue | - | - | - | - | 6.48x | 6.48x |
| EV / Revenue | - | - | - | - | 4.02x | 4.65x |
| EV / EBITDA | - | - | -11.2x | -3.8x | -9.55x | -7.37x |
| EV / EBIT | - | - | -11.1x | -3.77x | -9.32x | -7.25x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.007 | -0.011 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 9.5 | 9.5 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -4 | -6 |
| EBIT 1 | - | - | -8.389 | -11.6 | -4.1 | -6.1 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -4.1 | -6.1 |
| Net Debt 1 | - | - | -27.85 | -17.9 | -23.4 | -17.4 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.1200 | 0.1200 | 0.1200 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - | - |
| Announcement Date | 30/05/23 | 30/05/25 | 29/05/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.22x | - | -3.8x | - | 43.93M | |
| 20.35x | 7.16x | 14.38x | 1.46% | 69.18B | |
| 31.96x | 9.24x | 44.57x | 0.04% | 62B | |
| -73.2x | 14.15x | -68.23x | -.--% | 26.19B | |
| 29.82x | 6.33x | 16.44x | -.--% | 25.75B | |
| -14.7x | 5.35x | -6.73x | -.--% | 24.29B | |
| 26.87x | 5.1x | 16.96x | -.--% | 19.84B | |
| 45.45x | 16.69x | 33.86x | 0.33% | 15.65B | |
| -14.9x | 3360.83x | -17.18x | -.--% | 13.88B | |
| 1005.79x | 35.18x | 607.6x | -.--% | 14.09B | |
| Average | 105.22x | 384.45x | 63.79x | 0.2% | 27.09B | |
| Weighted average by Cap. | 63.09x | 181.79x | 42.15x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
